猪瘟病毒E2基因遗传变异及体外表达研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
针对频繁出现的弱毒疫苗免疫失败现象和免疫猪群持续带毒等猪瘟(CSF)防制中的重大问题,本项研究从病毒的分子水平入手,试图从病毒分子变异水平以及当前流行毒的分子差异程度澄清原因,并针对CSF的持续感染研制出高效安全的基因工程标记疫苗和诊断试剂,为彻底消灭CSF提供科学依据和技术支撑。主要研究内容包括:
     1.猪瘟病毒主要免疫原E2基因的序列分析:利用反转录PCR(RT-PCR)及套式PCR(nPCR)方法扩增了中国猪瘟兔化弱毒株(C株)兔脾组织毒保护性抗原E2(gp55)基因,成功地将其克隆并测定核苷酸序列,与国内外已发表的猪瘟病毒(CSFV)E2基因序列比较的结果是:C-株兔脾毒与C-株细胞(SK6)毒、C-株疫苗(犊牛睾丸细胞,CSFV-C)毒CSFV-SM株(石门)毒、Bresia株(荷兰)毒、Alfort株(德国)毒的E2核苷酸序列同源性分别为98.87%、98.34%、94.58%、91.00%、80.78%;氨基酸同源性分别为98.95%、97.37%、94.22%、91.60%、89.23%。对C-株兔脾毒与C-株细胞毒、经典强毒E2上的A、B、C三个中和性抗原区的氨基酸组成进行了比较,其结果为:C-株兔脾毒与C-株疫苗细胞毒的差异很小甚至没有差异。
     2.猪瘟病毒分子流行病学分析:利用RT-PCR及nPCR扩增并测定了我国近期(1997~2001年)12个省的51株流行野毒株的E2基因核酸序列。通过序列比较和系统发生关系分析发现:C-株兔组织毒、C—株细胞毒和中国50~60年代流行的石门强毒株同属于组群1(Group 1);近期猪瘟流行毒株均属于组群2(Group 2)的两个不同的亚组群(Subgroup2.1和2.2),表明我国目前流行毒株至少有2个亚组群。流行毒株与疫苗毒株有较大的差异(E2全基因核苷酸序列同源性82.2%~84.3%),表明猪瘟流行毒株已远离疫苗毒株的方向演变,明确了我国CSF流行趋势及我国CSFV在世界SCFV大系谱中的位置,并为基因工程疫苗的研究提供了基因储备。
     3.猪瘟病毒E2基因的真核表达:分别将CSFV两个代表株的E2基因克隆入毕赤酵母(P.Pastoris)分泌型表达载体pPIC9K中,酶切线型化后电穿孔导入P.Pastotis进行整合,经G418筛选得到25个高拷贝转化子,经DNA斑点试验和DNA测序证明外源基因E2稳定地整合到P.Pastoris染色体中。经甲醇诱导表达后,SDS-PAGE和Western blot结果证明了P.Pastoris培养上清液中含有正确糖基化的E2蛋白,表达量约250mg/L。重组P.Pastoris经连续培养8代仍可分泌特异性蛋白。免疫活性研究证明P.Pastoris表达的E2蛋白能刺激动物产生1:128~1:256猪瘟病毒的抗体。有望用于基因工程亚单位疫苗的研制。
     4.猪瘟病毒E2基因的密码子改造优化:低利用率密码子的数量和分布是影响外源基因有效表达的参数之一,优化密码子序列能够提高外源基因的表达。利用PCR基础上的定点突变方法对猪瘟病毒E2基因的24个密码子进行优化。优化后的E2基因转化P.Pastoris菌,甲醇诱导表达。诱导培养上清的SDS-PAGE和Western blot分析显示,E2蛋白在P.Pastoris中得到了高效的表达,表达量约1.08g/L。这表明对E2基因上低利用密码子的改造是成功的,
    
     猪瘟病毒EZ基因遗传变异及体外表达研究
    为进一步大规模生产打下了基础。
    5.毕赤酵母高效表达的培养条件探索:用PPastoris系统表达外源基因,对于不同的外源蛋
    白,表达量千差万别。除外源基因序列本身的内在特性起着很重要的作用外,表达条件对表
    达量高低的影响也极其显著。分别在不同时间、不同诱导型、不同pH、不同诱导剂量方面
    进行了较系统的对比:经不同时间表达,表明72小时蛋白可达峰值;采用抑制/诱导方式会
    提高表达量;表达EZ蛋白pH最佳值在7.5—8刀;最佳甲醇诱导量是2%~3%;得到了一套较
    完善的在PPastoris中表达CSFV EZ基因的条件,以供在规模化发酵罐中表达EZ基因蛋白
    生产亚单位疫茵。
    6.猪瘟病毒EZ基因的原核表达:PCR扩增出当前猪瘟流行野毒株,中国猪瘟兔化弱毒(C-
    株)兔脾组织毒EZ基因的主要抗原区,将其克隆到原核大肠杆菌表达载体PPROEX-HTb
    中诱导表达,经 SDS-PAGE检测表明,重组质粒能表达EZ基因主要区蛋白,Western blot
    检测表明,诱导表达蛋白与猪瘟阳性血清发生特异性反应,表达量为35%和38%,可用于
    基因工程诊断抗原。
    7.猪瘟病毒EZ基因的乳腺特异表达载体构建:将在乳腺细胞中特异分泌的信号肽序列连接
    到EZ基因,PCR得到了目的片段,再将pGFPCI载体上的Kana基因切下与在乳腺细胞中
    特异表达的P22载体连接,使其带有筛选标记,然后将带有信号肽的EZ插入到P22中,试
    图构建山羊乳腺上皮细胞的特异性表达载体。探索了构建的含目的基因的乳腺特异性表达载
    体调控成分的有效性,也为在体外培养的乳腺细胞中定位重组目的基因一体细胞克隆一动物
    乳腺生物反应器工作的开展作准备工作。
The E2 gene of CSFV C strain derived from rabbit spleen tissue was amplified by reverse transcription (RT) and nested Polymerase Chain Reaction (nPCR), then was cloned and sequenced. Compared with the published sequences of CSFV other virulent strains, the nucleotide homology of C strain from rabbit spleen tissue with strain C adapted to SK6 cell, Shimen, Brescia, Alfort strain were 98.87%, 94.58%, 91.00% and 80.78% respectively, and the amino acid homology were 98.95%, 94.22%. 91.60% and 89.23% respectively. There were little difference in the amino acid composition of antigen domain of A, B and C between C strain from rabbit spleen tissue and virulent strains above. This indicated that the prevalence of CSF and immunal failure may be not caused by the antigen variation of C stain vaccine virus.
    The E2 genes of 51 CSFV prevalent virulent strains isolated from 12 provinces in China were amplified and sequencd. The phylogenetic tree was constructed based on sequence comparison and analysis. The result showed that C strain derived from rabbit spleen tissue, C strain adapted to SK6 cell, Shimen virulent strain all belonged to group 1.1, and the prevalent virulent strains belonged to subgroup 2.1 or subgroup 2.2. This indicated there were at least two subgroups, which were prevailing in China, and the prevalent virulent strains were diverse far from C. strain vaccine virus.
    The E2 genes above of the prevalent Strain (Guangxi Yulin Strain) were cloned respectively into secreted expression vector pPIC9K of eukaryotic expression system P.Pastoris and transformed into P.Pastoris by electroporation after linearization, 25 high-copied transformants were obtained by G418 screening. It was proved that the E2 genes were integrated stably into chromosome of P.Pastoris by Dot blot and DNA sequencing. The results of SDS-PAGE and Western blot showed that the culture supernatant of transforments contained the correct glycosylated E2 protein and the recombinants could still secretedly express the specific proteins after culturing for 8
    
    
    generations. Studies on immune activity showed that the E2 protein expressed in P.Pastoris could induce animals to produce CSFV specific antibodies, the titre amounts to 1:128-1:256. This suggests proved that the E2 protein could protect animals against virulent virus of CSFV. Its the first time that the CSFV E2 protein was expressed successfully in eukaryotic expression system P.Pastoris.
    In order to improve the expression level of E2 gene in P.Pastoris, 24 low -usage codons for P.Pastoris were substitued by directed mutagnesis based on PCR. The optimized E2 gene was cloned into P.Pastoris expression vector pPIC9K and transformed into P.Pastoris SMD1168 host cell. The transformants were induced with methanol to express the interested gene .The results of SDS -PAGE and Western blot showed that E2 protein was expressed at high level, up to 1.08g/L.
    The expression conditions of E2 gene in P.Pastoris were optimized, the results indicated that the peak obtained after 72 hours;pattern of inhibition/ induction could improve expression level; The best pH value were between 7.5 and 8.0 and the optimized methanol-induced concentration was 2%-3%
    The E2 genes of the prevalent Strain (Guangxi Yulin Strain) and C strain derived from rabbit spleen tissue were amplified and cloned into E.coli the expression vector pPROEX-HTb respectively, the recombinant plasmids pPROEX-GXYL and pPROEX-C were obtained and then were transformed into the DH5a E.coli competent bacteria respectively, the recombinant bacteria could express the major antigen region of E2 gene, the expression yields amount to 35% and 38% repectively.
    The signal peptide sequence which was used for secretedly expressing divergent gene in mammary gland cells was ligated to the E2 gene, the E2 gene with signal sequence was obtained by PCR .The gene resisting kanamycin was cut down from pGFP-Cl vector and inserted into P22 vector, a P22 vector with gene resisting kanamycin was constructed, it was tried to construct an expression vector for trans
引文
1. Abdulaev NG, Popp MP, Smith WC. et al. Functional expression of bovine opsin in the methylotrophic yeast Pichia pastoris. Protein Expr Purif, 1997,10:61-69
    2. Afala M, Balint RF, Larric RJW. et al. Variable region sequence modulates periplasmic export of a singlechain FV antibody fragment in Escherichia Coli. Biotechniques, 1995, 18(5) : 832-841
    3. Andre H. Codon relacemont in the PAK1 gene: Experimental approach to study the role of based codan usage in gene expression. Molecular and cellular biology, 1987, 2914-2924
    4. Anonymous . Report of the scientific veterinary committee(adopted 17 septemer 1997) :the use of marker vaccines in the control of infectious disease in particular, classical swine
    
    fever .Document VI/8119/97-AL, commission of the European communites, 1997
    5. Anonymous. Measures to control classical swine fever in European wild boar. Proceedings of a meeting held in perugia. Document VI/7196/98-AL,commission of European Community, Italy, 1998, 6-7
    6. Arkowitz R A, Bassilana M. Protein translocation in Escherichia Coli. Biochim Biophys Acta, 1994, 1197(3) : 311-343
    7. Baker JA. Serial passage of hog cholera virus in rabbits. Proc.Soc.Exp.Biol.Med. 1946, 63:183-187
    8. Barr KA,Hopkins SA.Streekishna K. Protocol for Efficient Secretion of HAS Developed from Pichia pastoris. Pharm.Eng,1992, 12(2) :48-51
    9. Battista MC, Bergamini G, Campanini F. et al. Intracellular production of a major cytomegalovirus antigenic protein in the methylotrophic yeast Pichia pastoris. Gene, 1996, 176:197-201
    10. Beauvais A, Monod M, Debeaupuis JP et al. Biochemical and antigenic characterization of a new didpeptidyl-peptidase isolated from Aspergillus fumigatus.J Biol Chem,1997, 272:6238-3244
    11. Beauvais A, Monod M, Wyniger J et al. Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus ,a fugus pathogenic to humans.Infect Immun,1997, 65:3042-3047
    12. Behrens SE,Grassmann CW,Thiel HJ et al. Characterization of an autonomous subgenomic pestivirus RNA replicon. J Virol, 1998, 72:2364-2372
    13. Belyaev AS, Hails KS, Roy P. High-level expression of five-foreign genes by a single recombinant baculovirus. Gene, 1995, 229-233
    14. Berns A, Moorman R. Live attenuated pseudorabies virus expressing envelope glycoprotein El of hog cholera virus protects swine against both pseudorabies and hog cholera. J virol, 1991,65:2761-2765
    15. Bisaillon M, Bergeron J, Lemay G. Characterization of the nucleotide triphosphate phosphohydrolase and helicase activities of the reovirus lambda 1 protein. J Biol Chem. 1997,272:18,298-18
    16. Bjorklund H, Lowings P, Paton D. et al. Phylogenetic comparison and molecular epidemilogy of classical swine fever virus. Virus Genes, 1999, 19:189-195
    17. Blight MA, Holland IB. Heterologous protein secretion and the Versatile Escherichia coli haemolysin transiocator. Trends in Biotech, 1994, 12(11) : 450-455
    18. Bouma A, De Smit AJ,De Jong MC M et al. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine agaist classical swine fever
    
    virus.Vaccine, 2000, 18:1374-1381
    19. Boursonell et al Virology, 1990, 37:1032-1040
    20. Brandes HK, Hartman FC, Lu TY et al. Efficient expression of the gene for spinach phosphoribulokinase in Pichia pastoris and utilization of the recombinant enzyme to explore the role of regulatory cysteinyl residues by site-directed mutagenesis. J Biol Chem,1996, 271:6490-6796
    21. Brandkamp RG, Sreekrishna K, Smith PL et al. Expression of a synthetic gene encoding the anticoagulant-antimetastatic protein ghilanten by the methylotropic yeast Pichia pastoris. Protein Expr Purif,1995, 6:813-820
    22. Bruschke CJM, Hulst MM, Moormann RJM et al. Glycoprotein Erns of pestivirus induces apoptosis in lymphocytes of several species. J Virol,1997, 71:6692-6696
    23. Buckholz RG, Gleeson MA. Yeast systems for the commercial production of heterologous proteins. Biotechnology (N Y). 1991, 9(11) :1067-72. Review.
    24. Calera JA, Paris S Monod et al. Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatus. Infect.Immun,1996, 65:4718-4724
    25. Campbell SM, Rosen JM, Hennighauson LG et al. Comparison of the whey acidic protein gene of rat and mouse. Nucleic Acids Res, 1984, 12: 8685-8697.
    26. Carmona E, Dufour E, Plouffe C et al. Potency and selectivity of the cathepsin L1 propertide as an inhibitor of cysteine proteases. Biochemistry, 1996, 35:8149-8157
    27. CHang HK,Younghoon oh,Tae H Lee. Codon optimization for high-level expression of human erythropoitin(EPO) in mammalian cells.Gene,1997, 199:293-301
    28. Changchun Tu, Zongji Li, Hongwei Li et al. Phylogenetic comparison of classical swine fever virus in China. Virus Res, in press, 2001
    29. Chen CY, Oppermann H, Hitzeman RA. Homologous versus heterologous gene expression in the yeast, S.cereviside. Nucleic Acids Res.1984, 12:8951-8970
    30. Chen H, McCormick DB. Riboflavin 5'-hydroxymethyl oxidation. Molecular cloning, expression' and glycoprotein nature of the 5'-aldehyde-forming enzyme from Schizophyllum commune. J.Biol Chem. 1997, 272:20,077-20
    31. Chen YJ, Gonatas NK. The Golgi sialoglycoprotein MG160,expressed in Pichia pastoris,does not require complex carbohydrates and sialic acid for secretion and basic fibroblast growth factor binding. Biochem. Biophys. Res. Commun, 1997, 234:68-72
    32. Choi B-K, Jimenez-FIores R. Study of putative glycosylation sites in bovine β-casein introduced by PCR-based site-directed mutagenesis. J Agric Food Chem, 1997, 44: 358-364
    
    
    33. ChunS, Daheshia M, LeeS. Distribution fate and mechanism of immune modulation following mucosaldelivery of plasmid DNA encoding IL-10. J Immunol, 1999, 163: 2393
    34. Clare JJ, Rayment FB, Ballantine SP et al. High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene. Bio/Technology, 1991,9:455-460
    35. Clare JJ, Romanos MA, Rayment FB et al. Production of mouse epidermal growth factor in yeast: High-level secretion using pichia pastoris strains containing multiple gene copies. Gene, 1991, 105:205-212
    36. Clark AJ, Burl S, Denning C. Gene targeting in livestook: a preview.Trangenic Res, 2000, 9:263-275
    37. Cole CG,Henley RR.,Dale CN et al. History of hog cholera reseach in the US Department of Agriculture 1884-1960. Agriculture information Bulletin, (241) USDA, Washington DC
    38. Collet MS. Review article :Resent advances in pestivirus research. J Gen Virol,1989, 70:253-226
    39. Cormack BP, Bertram G, Egerton M et al. Yeast-enhanced green fluorescent protein(yEGFP):a reporter of gene expression in Candida albicaus. Microbiology, 1997, 143:303-311
    40. Cote HC, Pratt KP, Davie EW et al. The polymerization pocked "a"within the carborxyl-terminal region of the gamma chain of human fibrinogen is adjacent to but independent from the calcium-binding site. J Biol Chem,1997, 272:23,792-23,798
    41. Cregg JM, Madden KR, Barringer KJ et al. Functional characterization of the two alcohol oxidase genes from the yeast pichia pastoris. Mol Cell Biol, 1989, 9: 1316-1323
    42. Cregg JM, Vedvick TS, Raschke WC. Resent advances in the expression of foreign genes in pichai pastoris. Bio/Technology, 1993, 11: 905-910
    43. Cregg JM., Tschopp JF, Stillman C et al. High-level expression and efficient assembly of hepatitis B surface antigen in the mathylotrophic yeast,Pichia pastoris. Bio/Technology, 1987, 5:479-485
    44. Dahlen JR, Foster DC, Kisiel W. Expression, purification,and inhibitory properties of human proteinase inhibitor. Biochemistry, 1997, 36: 874-14,882
    45. David RH, James M, Cregg. Pichia Protocol. Hummana Press Inc,New Jersey, 1998
    46. David R, Higgins, James M et al. Pichia Protocols. New jersey, Humana Press Inc, 1998, 193-200
    47. Davis TR, Trotter KM, Granados RR et al. Baculovirus expression for alkaDine
    
    Phosphatase as a reporter gene for evaluation of production, glycosylation and secretion. Bio/Technology, 1992, 10: 1148-1150
    48. De Arce HD.Frias MT.Barrera M et al. Analysis of genomic differences between Cuban classical swine fever virus isolates.Poster presentation.OIE symposium On classical swine fever,Birmingham,United Kingdom, 1998, 9-10 July
    49. De Smit AJ,Bouma A,Van Gennip HGP et al.Chimeric (marker)C-strain virnses induce clinical protection against virulent classical swine fever virus(CSFV) and reduce transmission of CSFV between vaccinated pigs, vaccine, 201,19:1467-1476
    50. De Smit AJ, Bouna A, De Kluijver EP et al. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a sigle vaccination. Vet Microbiology, 2001,78:307-317
    51. De Vouge MW, Thaker AJ, Curran IH et al. Isolation and expression of a cDNA clone encoding an Alternaria alternata Alt a 1 subunit.Int.Arch. Allergy Immunol, 1996, 111:385-395
    52. De Vries Y, Arvidson D, Waterham et al. Functional characterization of mitochochondrial carnitine palmitoyltransferases I and II expressed in the yeast Pichia pastoris. Biochemistry, 1997, 36:5285-5292
    53. Degano P, Sarphie DF, Bangham CR. Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system. Vaccine. 1998 , 16(4) :394-8.
    54. Depner KR, Muller A, Gruber A et al. Classical swine fever in wild boar(susscrofa)-experimental infections and viral persistence.Ptsch , Tierarztl, Wochens-chr, 1995, 102:381-384
    55. Depner KR, Rodriguez A, Pohlenz J et al. Persistent classical swine fever virus infection in pigs infected after weaning with a virus isolated during the 1995 epidemic in Germany:clincal,virological,serological and pathological findings. Eur J Vet Path, 1996,2:61-66
    56. Despreaux CW, Manning RF. The dacA gene of Bacillus stearothermophillus colding for D-alanine carboxypeptidase:cloning,structure and expression in Escherichia coli and Pichia pastoris. Gene, 1993, 131:35-41
    57. Digan ME, Lair SV, Brierley RA W et al. Continuous production of a novel lysozyme via secretion from the yeast, Pichia pastoris. Bio/Technology, 1989, 7:160-164
    58. Doring F, Theis S, Daniel H. Expression and functional charaterization of the mammalian intestinal peptide transporter PepT1 in the methylotropic yeast Pichia pastoris. Biochem Biophys Res Commun,1997,232:656-662
    
    
    59. Ebeet K, Di Tullio P, Barry CA et al. Induction of human tissue plasminogen activator in the mammary gland of transgenic goats. Bio/Technology, 1994, 12: 699-702
    60. Ebert KM, Selgrath JP, Ditullio P et al. Transgenic production a Variant of human tissue-type plasminogen activator in goat milk: Gene ration of trans-genie goats and analysis of expression. Bio/Technology, 1991, 9: 835-838
    61. Eckhart L, Raffelsberger W, Ferko B, Klima et al. Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus. J Gen Virol, 1996, 77:2001-2008
    62. Edwards S, Fukusho A, Lefevre P et al. Classical swine feventhe global situation .Vet Microbiol, 2000,73:103-119
    63. Edwards S, Moennig V, Wensvoort G. The development of an international reference panel of monoclonal antibodies for the differentiation of hog cholera virus from other pestiviruses. Vet Microbiol, 1991,29:101-108
    64. Edwards S. Suivival and inactivation of classical swine fever virus. Vet Microbiol, 2000,73:175-181
    65. Ellis SB, Brust PF, Koutz PJ et al. Isolation of alcohol oxidase and two other methanol requlatable genes from the yeast pichia pastoris. Mol Cell Biol, 1985, 5: 1111-1121
    66. Fahnestock SR, Bedzyk LA. Production of synthetic spider dragline slik protein in Pichia pastoris . Appl Microbiol Biotechnol, 1997, 47:33-39
    67. Ferrari E, Lodi T, Sorbi RT et al. Expression of a lipocalin in Pichia pastoris: secretion, purification and binding activity of a recombinant mouse major uinary protein. FEBS Lett, 1997, 401:73-77
    68. Fierobe H-P, Mirgorodskaya E, Frandsen RP et al. Overexpression and characterization of Aspergillus awamori wild-type and mutant glucoamylase secreted by the methylotrophic yeast Pichia pastoris: comparison with wild-type recombinant glucoamylase produced using Saccharomyces cerevisiae and Aspergillus niger as hosts. Protein Expr.Purif, 1997, 9:159-170
    69. Freitas TR, Caldas LA, Rebello MA. Protaglandin A1 inhibits replication of classical swine fever virus. Mem Inst Oswaldo Cruz,1998, 93(6) :815-818
    70. Fryxell KB, O' Donoghue K, Graeff RM et al. Functional expression of soluble forms of human CD38 In Escherichi coli and Pichia pastoris. Protein Expr Purif, 1995, 6:329-336
    71. Gachhui R, PrestaA, Bentley DF et al. Characterization of the reductase domain of rat neuronal nitric oxide synthase generated in the methyotrophic yeast Pichia pastoris. Calmodulin response is complete within the reductase domain itself. J Biol Chem,1997,
    
    271:20,594-20,602
    72. Gerber A, O' Connell MA, Keller W. Two forms of human double-stranded RNA-specific editase 1 (hREDl)generated by the insertion of an Alucassette. RNA, 1997, 3:453-463
    73. Gerdts V, Vons A2 Mettenleiter TC. Potency of an experimental DNA Vaccineagamst Aujeszkys disease in pigs. Vet Microbiol, 1999, 66:1-13
    74. Germain RN .MHC-dependent antigen processing and peptide presentation: providining Ligands for T lymphocyte activation. Cell, 1994, 76: 287-299
    75. Gerstmayer B, Altenschmidt U, Hoffmann M et al. Costimulation of T cell proliferation by a chimeric B7-2 antibody fusion protein specifically targeted to cells expressing the erbB2 proto-oncogene. J Immunol, 1997, 158:4584-4590
    76. Gerstmayer B, Pessara U, Wels W. Construction and expression in the yeast Pichia pastoris of functionally active soluble forms of the human costimulatory molecules B7-1 and the B7-2 counter-receptor CTLA-4 FEBS Lett, 1997, 407:63-68
    77. Goochee CF, Grame MJ, Anderson DC et al. The oligosaccharides of glycoproteins: Bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties. Bio/Technology, 1991, 9: 1347-1355
    78. Gordon JW, Ruddle FH. Integration and stable germ-line transmission of genes injected into mouse pronuclei. Science, 1981, 214: 1244-1246
    79. Gordon K, Lee E, Vitale JA et al. Production of human tissue plasminogen activator in transgenic mouse milk. Bio/Technology, 1987, 5:1183-1187
    80. Greiser-Wilke I, Depner K, Fritzemeier J et al. Application of a computer program for genetic typing of classical swine fever virus isolates from Germany. J Virol Meth, 1998,75:141-150
    81. Grinna LS, Tschopp JF. Size distribution and general structural features of N-linked oligosaccharides from the methylotrophic yeast, Pichia pastoris. Yeast. 1989 , 5(2) :107-15.
    82. Guo W, Gonzalez-Candelas L, Kolattukudy PE. Identification of a novel pelD gene expressed uniquely in planta by Fusarium solani f.sp.pisi(Nectria haematococca,mating type VI) and characterization of its protein product as an endo-pectate lyase. Arch Biochem Biophys. 1996, 332: 305-312
    83. Haagmans BL, vanRooij EM, Dubelaar M et al. Vaccination-of pigs against pseudorabies virus with plasmid DNA glgcoprotein D. vaccine, 1999, 5:1264-1271
    84. Hagenson MJ, Holden KA, Parker KA et al. Expression of streptokinase in Pichia pastoris yeast. Enzyme Microb.Technol, 1989,11:650-656
    85. Halter R, carnwath J, Espanion G et al. Strategies to express fater VIII gene coustruct in the
    
    ovine mammary gland. Theriogenology, 1993, 39: 137-149
    86. Hammond JM, Mccoy RJ, Janson ES et al. Vaccination with a single dose of arecombinant porcine adenovirus expressing the classical swine fever virus gp55(E2) gene protects pigs against classical swine fever. Vaccine, 2000, 18(1-12) :1040-1050
    87. Hansen OC, Stougaard P. Hexose oxidase from the red alga Chondrus crispus. Purification, molecular cloning,and expression in Pichia pastoris. J Biol Chem.1997, 272: 11,581-587
    88. Hanson RJ. Origin of hog cholera. J Am Vet Med Assod, 1957, 131:211-218
    89. Haq TA, Mason HS, Clements JD et al. Oral Immunization with recombinant bacterial antigen produced in transgenic plants. Science, 1995, 268: 714-716
    90. Harkness JW. Classical swine fever and its diagnosis: A current view. VetRec, 1985,16:288-293
    91. Harmsen MC, Heeringa P, Van der Geld YM et al. Recombinant proteinase 3(Wegener antigen) expressed in Pichia pastoris is functionally active and is recognized by patient sera. Clin Exp Immunol, 1997, 110:257-264
    92. Harris S, AH S, Asnderson S et al. Complete nucleotide sequence of the ovine b-lactoglobulin gene. Nucleic Acids Res. 1988, 19: 10379-10380
    93. Harris, Mc Clenaghan M, Simons JP et al. Gene expression in the mammary gland. J Reprod Fert, 1990, 88:707-715
    94. Hasan UA, Abai AM, Harpe DR. Nucleic acid immunizationxoncepts and techniques associated with third generation vaccines. J immunol Methods, 1999, 229: 1-22
    95. Hasslacher M, Schall M, Hayn M et al. High-level intracellular expression of hydroxynitrile lyase from the tropical rubber tree Hevea brasilliensis in microbial hosts. Protein Expr Purif. 1997,11:61-71
    96. He C, Alexander JJ, Lim A et al. Production of the rat complement regulator, Crry,as an active soluble protein in Pichia pastoris. Arch Biochem Biophys, 1997, 341:347-352
    97. Henri PF. Overexpression and characterization of Aspergillus awamori wildtype and mutant glucoamylase secreted by the methylotrophic yeast pichia pastoris: Comparison with wild-type recombinant glucoamylast. Protein Expression and purification, 1997, 9:199-170
    98. Higuchi R, Krummel B, Saiki RK. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 1988, 16(15) :7351-67.
    99. Ho SN, Hunt HD, Horton RM et al. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene,1989,77:51-59
    
    
    100. Hockney RC. Recent developmonts in heterologous protein production in Escherichia Coli. Trends in Biotech, 1994, 12(11) : 456-463
    101. Hoekema A, Kastelein RA,Vasser M et al. Codon replacement in the pGK1 gene of saccharomyces cerevisiae:Experimental approach to study the role of biased codon usage in gene expression. 1987, 7(8) :2914-2924
    102. Hofmann MA, Brechtbuhl K, Stauber N. Rapid characterization of new pestivirus strains by direct sequencing of PCR-amplified cDNA from the 5'non-coding region. Arch Virol, 1994, 139:217-219
    103. Hofmann MA, Bassy S. Classical swine fever in 1993 in switzerland:molecular epidemiologic characterization of the virus isolate. Schweiz Arch Tierheilkd , 1998,140:365-370
    104. Hollenberg CP, Gellissen G. Production of recombinant Proteins by methylotrophic yeasts. Curr opin Biotechnol, 1997, 8(5) :554-560
    105. Holmquist M, Tessier DC, Cygler M. High-level production of recombinant Geotrichum candidum lipases in yeast Pichia pastoris. Protein Expr Purif, 1997, 11:35-40
    106. Hooft van Iddekinge BJ, De Wind N, Wensvoort G et al. Comparison of the protective efficiency of recombinant pseudorabies virus against pseudorabies and classical swine fever in pigs :influence of different promoters on gene expression and on protection. Vaccine, 1996,14:6-12
    107. Hsiung HM, Cantrell A, Luirink J et al. Use of bacreriocin reiease protein of E. Coli for excression of human growth hormone into the culture medium. Bio/Technokgy, 1989, 7(3) : 267-271
    108. Hulst MM, Westra DF, Wensvoort G. Glycoprotein El of hog cholera virus expressed in insect cells protects swine from hog cholera. J Virol. 1993,67:5435-5442
    109. Hulst MM, Moormann RLM. Inhibition of pestivirus infection in cell culture by envelope proteins Erns and E2 of classical swine fever virus: Erns and E2 interact with different receptors. J Gen Virol, 1997, 78:2779-2789
    110. Hulst MM, Himes G, Newbigin E et al. Glycoprotein E2 of classical swine fever virus:expression in insect cells and identification as a ribonuclease. Virology, 1994, 200: 558-565
    111. Hulst MM, Panoto FE, Hoekman A et al. Inactivation of the RNase activity of glycoprotein Erns of classical swine fever virus results in a cytopathogenic virus. J Virol, 1998,72(1) :151-157
    112. Hulst MM, van Gennip HGP, Moormann RJM. Passage of classical swine fever virus in
    
    cultured swine kidney cells selects virus variants that bind to heparan sulfate due to a single amino acid change in envelope protein Erns. J Virol, 2000, 74(20) :9553-9561
    113. Ikegaya K, Hirose M., Ohmura T, Nokihara K. Complete deter mination of disulfide forms of puified recombinant human serum albumin,secreted by the yeast Pichia pastoris. Anal Chem, 1997, 69:1986-1991
    114. Illy C, Quraishi O, Wang J et al. Role of the occluding loop in cathepsin B activity. J Biol Chem, 1997,272:1197-1202
    115. International Animal Health Code. 1998, edication part 2, chapter 2. 1. 1.
    116. Invitrogen BV. Pichia expression kit.protein expression.A manual of methods for expression of recombinant proteins in pichia pastoris.cotalog no.k1710-01
    117. Ishikawak. Rrch Virol.1994,140-148
    118. J.Sambrook, EF Fritsch, T Maniaatis. Molecular Cloning. A Laboratory Manual 2nd. Cold Spring Harbor Laboratory Press. 1989
    119. Jerva LF, Sullivan G, Lolis E. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2 sequence analysis and mutagenesis identify receptor binding isotopes. Protein Aci, 1997, 6:1643-1652
    120. Jonsson LJ, Saloheimo M, Penttila M. Laccase from the white-rot fungus Tramates versicolor: cDNA cloning of lccl and expression in Pichia pastoris. Curr Gene, 1995,32:425-430
    121. Jonsson LJ, Saloheimo M, Penttila M. Current Genetics. 1997, 32(6) : 425-430
    122. Joseph M. Fernandez, James P Hoeffler. Gene Expression Systems. New-york, Academic Press, 1999
    123. Juge N, Andersen JS, Tull D et al. Overexpression, purification, and characterization of recombinant barley α-amy-lases 1 and 2 secreted by the methylotrophic yeast Pichia pastoris. Protein Expr Purif, 1996, 8:204-214
    124. Julius D, Brake A, Blair L et al. Isolation of putative structural gene for the lysine-arginine-cleaving endopeptidese required for processing of yeast prepro-a-factor. Cell, 1985,37:1075
    125. Kabin G. In vitro merkmale des schweinepestivirus. Zentralbl Veterinarmed[B], 1967,14:543-552
    126. Kalandadze A, Galleno M, Foncerrada L et al. Expression of recombinant HLA-DR2 molecules. Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR ap heterodimers.J Biol Chem,1996, 271:20,156-20,162
    
    
    127. Kawata Y, Sakiyama F, Tamaoki H. Amino-acid sequence of ribonuclease T2 from Aspergillus oryzae. Eur J Biochem, 1988, 176:683-697
    128. Kimman JG. Cellular immune response to hog cholera virus(HCV):T cells of immune pigs proliferate in vitro upon stimulation with live HCV.but the El envelope glycoprotein is not a major T-cell antigen. J Virol, 1993,67,2922-2927
    129. Kiselyov VV, Berezin V, Maar TE et al. The first immunoglobulin-like neural cell adhesion molecule(NCAM)domain is involved in double-reciprocal interaction with the second immunoglobulin-like NCAM domain and in heparin binding. J Biol Chem, 1997, 272:10125-10134
    130. Klavinskis LS, Barnfield CH , Gao L. Mtranasal immunization with plasmid DNA-Lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J immunol, 1999, 162:254
    131. Knoetig SM, Summerfield A, Spagnuolo-Weaver M et al. Immunopathogenesis of classical swine fevenrole of monocytic cells. Immunology, 1999, 97(2) :359-366
    132. Kolupaera VG, Pestova TV, Hellen CU. Ribosomal binding to the internal ribosomal entry site of classical swine fever virus. RNA, 2000, 6(12) :1791-1807
    133. Konig M, Lengsfeld T, Pauly T, Stark R et al. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol. 1995, 69, 6479-6486
    134. Koprowski H, James TR,Cox HR. Propagation of hog cholera virus in rabbits. Proc Soc Exp Biol Med, 1946,63:178-183
    135. Kosmidou AR, Ahl R, Thiel H-J et al. Differentiation of classical swine fever virus(CSFV) strains using monoclonal antibodies against structural glycoprotein. Vet Microbiol, 1995, 47:111-118
    136. Kotake H, Li Q, Ohnishi T et al. Expression and secretion of rabbit plasma cholesteryl ester transfer protein by Pichia pastoris. J Lipid Res, 1996, 37:599-605
    137. Koutz P, Davis GR, Stillman C et al. Structural comparison of the Pichia Pastoris alcohol oxidase genes. Yeast, 1989, 5: 167-177
    138. Krimpenfort P, Rade makers A, Eyestone W et al. Generation of transgenic dairy cattle using "in vitro" embryo production. Bio/Technology, 1991, 9:844-847
    139. Kukuruzinska MA, Bergh ML, Jackson BJ. Protein glycosylation in yeast. Annu Rev Biochem. 1987, 56:915-44. Review.
    140. Laddomada A. Incidence and control of classical swine fever in European wild boar. Vet Microbiol, 2000,73(2-3) : 121-130
    
    
    141. Lakey D.Voladri RKR, Edwards KM et al. Ehanced production of recombinant mycobacterium tuberculosis antigens in Escherichia coli by replacement of lowusage codons. Infection and immunity. 2000, 68(1) :233-238
    142. Lai SK, Tulasiram P, Jameel S. Expression and characterization of the hepatitis E virus ORF3 protein in the methylotrophic yeast. Pichia pastoris. Gene, 1997, 190:63-67
    143. Laroche Y, Storme V, De Meutter J et al. High-level secretion and very efficient isotopic labeling of tick anticoagulant peptide(TAP)expressed in the methylotrophic yeast,Pichia pastoris. Biotechnol NY, 1994, 12:1119-1124
    144. LaVallie ER, DiBlasion EA, Kovacic S et al. A thioredoxin gene fusion expression system that circumvents elusion body formation in the E.Coli cytoplasm. Bio/Technology, 1993, 11(2) : 187-193
    145. Lee WC, Wang CS, Chien MS. Virus antigen expression and alteration in peripheral blood mononuclear cell subpopulations after classical swine fever virus infection. VetMicrobiol, 1999, 67(1) :17-29
    146. Leif. Lactase from the white-rot fungs trametes versicoloncDNA cloning of lccl and expression in Pichia pastoris. Curr Gene, 1997, 32:425-430
    147. Liao YF, Lai A, Moremen KW. Cloning, expression, purification, and characterization of the human broad specificity lysosomal acid a-mannosidase. J Biol Chem, 1997, 271:28348-28458
    148. Liess B, Schurian E. Inaktivierende wirkung von TEGO 51/15 DL im suspension sversuch mit zwei virusarten der Toga-Gruppe:de Euro paischen schweinepest and der Bovinen virusdiarr hoe-Mucosal Disease. Archir Fur lebensmittelhygiene, 1973, 24:154-157
    149. Lima CD, Klein MG, Weinstein IB et al. Three-dimensional structure of human protein kinase C interacting proteinl, a member of the HITfamily of proteins. Proc.Natl Acad Sci USA, 1996, 83:5357-5362
    150. Lin M, LinF, Mallory M et al. Deletions of structural glycoprotein E2 of classical swine fever virus strain Alfort/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for bingding immunoglobulin G antibodies of a pig hyperimmune serum. J Virol, 2000, 74(24) : 11619-11625
    151. Linnevers CJ, McGrath ME, Armstrong R et al. Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex. Protein. Sci, 1997,6:919-921
    152. Liu JJ.Wong ML. The recombinant nucleocapsid proteins of classical swine fever virus can act as a transcriptional regulator. Virus Res, 1998, 53:75-80
    
    
    153. Loewen MC, Liu X, Davies PL et al. Biosynthetic production of type II fish antifreeze protein:fermentation by Pichia pastoris. Appl Microbiol Biotechnol, 1996, 48:480-486
    154. Lowing P, Ibrate G, Needham J et al. Classical swine fever virus diversity and evolution. J Gen Virology, 1996,77:1311-1321
    155. Lowings JP, Paton DJ, Sands JJ et al. Classical swine fevengenetic detection and analysis of differences between isolates. JGen Virol, 1994, 75:3461-3468
    156. Lowings P, Ibata G, De Mia et al. Classical swine fever in Sardinia epidemiology of recent outbreaks. Epidemiol Infect, 1999,122:553-559
    157. Luckow VA, Sunners MD. Trends in the development of baculovirus expression vectors. Bio/Technology, 1998,6: 47-55
    158. Luo D, Mah N, Krantz M et al. V1-linker-Vh orientation-dependent expression of single chain Fv-containing an engineered disulfide-stabilized bond in the framework regions. J Biochem Tokyo, 1995, 118:825-831
    159. Ma JK-C, Hein MB. Immunotnerapeutic potein of antibodies produced in plants. Trends Biotechuol, 1995, 13:522-527
    160. Mac WT. High-Yield Secretion of recombinant geltions by Pichia Pastris. Yeast, 1999, 15:1087-1096
    161. Maga EA, Anderson GB, Huang MC et al. Expression of human hysozyme mRNA in the mammary gland of transgenic mice. Transgenic Res, 1994, 3: 36-42
    162. MarcWT. High-yield secretion of recombinant gelation by pichia pastoris. yeast, 1999, 15:1087-1096
    163. Markaryan A, Beall CJ, Kolattukudy PE. Inhibition of Aspergillus serine proteinase by Streptomyces subtilisin inhibitor and high-level expression of this inhibitor in Pichia pastoris.Biochem. Biophys Res Commun, 1996, 220:372-376
    164. Markowska-Daniel I, Pejsak Z, Winnicka A et al. Phenotypic analysis of peripheral leulocytes in piglets infected with classical swine fever virus. Res Vet Sci, 1999, 67(1) :53-57
    165. Martinet W, Saelens X, Deroo T et al. Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase. Eur J Biochem, 1997, 247:332-338
    166. Masure S, Paemen L, Proost P et al. Expression of a human mutant monocyte chemotactic protein 3 in Pichia pastoris and characterization as an MCP-3 receptor antagonist. J Interferon Cytokine Res, 1995, 15:955-963
    167. Masure S, Paemen L, Van Aelst I et al. Production and characterization of recombinant
    
    active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration. Eur J Biochem, 1997, 244:21-30
    168. McCollum D, Mononsov E, Subramani S. The pas8 mutant of Pichia pastoris exhibits the peroxisomal protein import deficiencies of Zellweger syndrome-the PAS8 protein binds to the COOH-terminal tripeptide peroxisomal targeting signal.and is a member of the TPR protein family. J.Cell Biol, 1993, 121:761-774
    169. McGrew JT, Leiske D, Dell B, Klinke R et al. Expression of trimeric CD40 ligand in Pichia pastoris: use of a rapid method to detect high-leel expressing transformants. Gene, 1997, 187:193-200
    170. Meade H, Gates L, Lacy E et al. Bovine asl-casein gene sequences direct high level expression of active urokinase in mouse milk. Bio/Technology, 1990, 8: 443-446
    171. Mellor J, Dobson MJ.Roberts NA et al. Factors affecting heterologous gene expression in saccharomyces cerevisiae. Gene, 1985,33:215-226
    172. Mengeling WL, Paker RA. Pathogenesis of chronic hog cholera. Am J Vet Res, 1969, 30:409-417
    173. Merkel RK, Zhang Y, Ruest PJ et al. Cloning,expression,purification,and characterization of the murine lysosomal acid a-mannosidase. Biochim.Biophys Acta, 1336,132-146.
    174. Meyer H, Liess B, Hermanns W, et al. Diaplazentare infektion von schweinefeten mit dem virus der Europaischen Schweinepest(ESP).Virologische und serologische untersuchungen in der postmatalen phase.Fortschritte der Veterinarmedizin. suppl.zbl. Vet Med, 1980, 30:140-144
    175. Meyers G, Rumenapf T, Thiei H J. Molecular cloning and mucleotide sequence of the genome of hog cholera virus. J Virology, 1989, 171: 555-567.
    176. Meyers G, Thiel H-J. Cytopathogenicity of classical swine fever virus caused by defective interfering particles. J Virol, 1995, 69:3683-3689
    177. Meyers G, Thiel HJ. Molecular characterization of pestivirus. Advance in virus reseach.1996,47:53-118
    178. Meyers G, Saalmuller A, Buttner M. Mutations abrogating the RNase activity in glycoprotein Erns of the pestivirus classical swine fever virus. J Virol, 1999, 73(12) :10224-10235
    179. Meyers G, Thiel HJ, Rumenapf T. Classical swine fever virus:recovery of infectious viruses from cDNA constructs and generation of recombginant cytopathogenic defective interfering particles. J Virol, 1996,70:1588-1595
    180. Michael JO Donbue. Over expression in Pichia Pastries and crystallization of an elicidor
    
    protein secreted by the phytopathogenic fungus. Protein Experessionand Purification, 1996, 8:254-261
    181. Mistry AR, Falciola L, Monaco L et al. Recombinant HMG1 protein produced in Pichia pastoris: a nonviral gene delivery agent. Biotechniques, 1997, 22:718-729
    182. Mittelholzer C, Moser C, Tratschin JD et al. Porcine cells persistently infected with classical swine fever virus protected from pestivirus-induced cytopathic effect. J Gen Virol, 1998,79:2981-2987
    183. Moennig V, Plagemann GW. The pestiviruses. Adv Virus Res, 1992, 41:53-98
    184. Moennig V. Characteristics of the virus.In:Liess,B.(Ed.)Classical swine fever andrelated infections. Martinus Nijhoff, Boston, Dordrecht, Lancaster, 1988,pp55-80
    185. Moennig V. The hog cholera virus. Immun.Microbiol Infect Dis, 1992, 15(3) : 189-201
    186. Mononsov EZ, Wenzel TJ, Luers GH et al. Labeling of peroxisomes with green fluorescent protein in living P.pastoris cells. J Histochem Cytochem, 1996, 44:581-589
    187. Moormann RJM, VanGennip HGP, Miedema GKW. Infectious RNA Transcribed from an Engineered fun-length cDNA templote of the genome of pestivirus. Virol, 1996, 70 (2) : 763-770.
    188. Moormann RJM, Warmerdam PAM, Vander Mer BVD et al. Molecular cloning and nucleotide sequence of hog cholera virus strain. Brescia and mapping of the genomic region encoding envelope glycoprotein El. Virology, 1990, 177: 184-198.
    189. Moormann RJM, Bouma A, Kramps JA et al. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. 2000, 73(2-3) :209-220
    190. Moormann RJ, Bouma A, kramp SJA et al. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. 2000, 73(2-3) :209-220
    191. Moormann RJ, van Gennip HG, Miedema GK et al. Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus. J Virol. 1996, 70(2) :763-70.
    192. Morel N, Massoulie J. Expression and processing of vertebrate acetylcholinesterase in the yeast Pichia pastoris. J Biochem, 1997,328:121-129
    193. Moser C, Stettler P, Tratschin J-D et al. Cytopathogenic and noncytopathogenic RNA replicons of classical swine fever virus. J Virol, 1999, 73(9) :7781-7794
    194. Mulder WAM, priem J, Glazenbura KL et al. Virulence and pathogenesis of non virulent and virulent strains of pseudorabies virus expressing envelope glyoproteins El of hog cholera virus. J Gen virol, 1994, 75:117-124
    195. Munshi C, Lee HC. High-level expession of recombinant Aplysia ADP-riboxyl cyclase in
    
    Pichia pastoris by fermentation. Protein Expr Purif, 1997, 11:104-110
    196. Nilsen SL, DeFord ME, Prorok M et al. High-level secretion in Pichia pastoris and biochemical characterization of the recombinant kringle 2 domain of tissue-type plasminogen activator. Biotechnol Appl Biochem,1997, 25:63-74
    197. O'Donohue MJ, Boissy G, Huet JC et al. Overexpression in Pichia pastoris and crystallization of an elicitor protein secreted by the phytopathogenic fungus.Phytophthora cryptogea. Protein Expr.Purif, 1996, 8:254-261
    198. Ohsawa I, Hirose Y, Ishiguro M et al. Expression,purification,and neurotrophic activity of amyloid precursor protein-secreted forms produced by yeast. Biochem Biophys Res Commun, 1995,213:52-58
    199. OIE lists A and B Disease.
    200. Okabayashi K, Tsujikawa M, Morita M et al. Secretory production of recombinant urokinase-type plaminogen activator-annexin V chimerase in Pichia pastoris. Gene, 1996, 177:69-76
    201. Parchariyanon S, Damrongwatanapokin S, Inui K et al. Different genetic spectrum of classical swine fever virus in Thsiland. Proceedings of the 15th IPUS congress, Birmingham, England, 5-9 July, 1998,p358
    202. Paton DJ, McGoldrick A, Belak S et al. Classical swine fever virus:a ring test to evaluate RT-PCR detection methods. Vet Microbiol, 2000b, 73:159-174
    203. Paton DJ, McGoldrick A, Greiser-Wilke I et al. Genetic typing of classical swine fever virus. Vet Microbiol, 2000, 73(2-3) :135-157
    204. Paul MS. Codon usage in yeast: cluster analysis clearly differentiates highly and lowly expressed genes. Nucleic Acids Research, 1986,14(3) : 5125-5143
    205. Payne MS, Petrillo KL, Gavagan JE et al. Engineering Pichia pastoris for biocatalysis: co-production of two active enzymes. Gene, 1997,194:179-182
    206. Payne MS, Petrillo KL, Gavagan JE et al. High-level production of spinach glycolate oxidase in the methylotrophic yeast Pichia pastoris:engineering a biocatalyst. Gene ,1995, 167:215-219
    207. Peeters B, Bienkowsla SK, Hulst M et al. Biologically safe.non-transmissible pseudorabies virus vector vaccine protects pigs against both Aueszkjs disease and classical swine fever. J General virology, 1997, 78: 3311-3315
    208. PengYC, Acheson NH. Production of active polyomavirus large T antigen in yeast Pichia pastoris. Virus Res, 1997,49:41-47
    209. Pestova TV, Shatsky IN, Fletcher SP.et al. A prokaryotic-like mode of cytoplasmic
    
    eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev, 1998, 12(1) : 67-83
    210. Petersen A, Grobe K, Lindner B et al. Comparison of natural and recombinant isoforms of grass pollen allergens. EIectrophoresis,1997, 18:819-825
    211. Piedrahia JA. Targeted modification of the domestic animal genome. Theriogenology, 2000,9:263-106
    212. Powell RM, Ward T, Evans DJ et al. Interaction between echovirus 7 and its receptor,decay-accelerating factor (CD55) : evidence for a secondary cellular factor in A-particle formation. J Virol, 1997, 71:9306-9312
    213. Qin YM, Poutanen MH, Helander HM et al. Peroxisomal multifunctional enzyme of p-oxidation metabolizing D-3-hydroxyacyl-CoA esters in rat livenmolecular cloning, expression and characterization. Biochem J, 1996, 321:21-28
    214. Reddy RG, Yoshimoto T, Yamamoto S et al. Expression, purification, and characterization of porcine leukocyte 12-lipoxygenase produced in the methylotrophic yeast, Pichia pastoris. Biochem.Biophys. Res Commun, 1994, 205: 381-388
    215. Ridpath JF, Bolin SR, Dubovi EJ. Segregation of bovine viral diarrhea virus into genotypes. Virology, 1994, 205:66-74
    216. Rijnbrand R, Bredenbeek PJ, Haasnoot PC et al. The influence of downstrenm protein-coding sequence on internal ribosome entry on hepatitis C virus and other lavivirus RNAs. RNA, 2001, 7(4) :585-597
    217. Rijnbrand R, van der Straaten T, van Rijn PA et al. Internal entry of ribosomes is directed by the 5 ' noncoding region of classical swine fever virus and dependent on the presence of an RNA pseudoknot upstream of the initiation codon. J Virol, 1997, 71(1) :451-457
    218. Rodriguez M, Rubiera R, Penichet M et al. High level expression of the B.microplus Bm86 antigen in the yeast Pichia pastoris forming highly immunogenic particles for cattle. J Biotechnol, 1994,33:135-146
    219. Romanes MA, Scorer CA, Clare JJ. Foreign gene expression in yeast: a review. Yeast. 1992, 8(6) :423-88. Review.
    220. Romanos MA, Clare JJ, Beesley KM et al. Recombinant Bordetella pertussis pertactin (P96) from the yeast Pichia pastoris:high-level production and immunological properties. Vaccine. 1991,9:901-906
    221. Romero PA, Lussier M, Sdicu AM et al. Ktrlp is an α-1,2-mannosyltransferase of Saccharomyces cerevisiae.Comparison of the enzymic properties of soluble recombinant Ktrlp and Kre2p/Mntl1p produced in Pichia pastoris. Biochem.J, 1997, 321:289-295
    
    
    222. Rosenfeld SA, Nadeau D, Tirado J et al. Production and purification of recombinant hirudin expressed in the methylotrophic yeast Pichia pastoris. Protein Expr Purif, 1996, 8:476-482
    223. Rosenfeld SA, Ross OH, Hillman MC et al. Production and purification of human fibroblast collagenase(MMP-l)expressed in the mathylotrophic yeast Pichia pastoris. Protein Expr Purif, 197, 7:423-430
    224. Ruddat A, Schmidt P, Gatz C et al. Recombinant type A and B phytochromes from potato. Transient absorption spectroscopy. Biochemistry,1997,36:103-111
    225. Ruggli N, Moser C, Mitchen D et al. Baculovirus expression and affinity purification of protein E2 of classical swine fever virus strain Alfort/187. Virus genes, 1995, 10(2) :115-126
    226. Ruggli N, Tratschin JD, Mittelholzer C et al. Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA . J Virol, 1996, 70:3478-3487
    227. Rumeapf T, Stark R, Meyer G et al. Structural proteins of hog cholera virus expressed by vaccinia virus:further characterization and induction of protective immunity. J virol, 1991, 65:589-597
    228. Rumenapf T, Stark R, Heimann M et al. N-terminal proteinase of pestivirus: identification of putative catalytic residues by site-directed mutagenesis. J Virol, 1998, 72(3) :2544-2547
    229. Rumenapf T, Stark R, Meyers G et al. Structural proteins of hog cholera virus expressed by vaccinia virus:further characterization and induction of protective immunity. J Virol, 1991, 65:589-597
    230. Rumenapf T, Unger G, Strauss JH et al. Processing of the envelope glycoproteins of pestiviruses. J Virol, 1993, 67:3288-3294
    231. Rumenapf T. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J Virol, 1991, 67:589-597
    232. Rumenapf Y. Processing of the envelope glycoproteins of pestivirus. J Virol, 1993, 67: 3288-3294
    233. Russell AD, Hugo WB. Chemical disinfectants.In:Linton,AH,Hugo WB,Rus sell AD (Eds),Disinfection in veterinary and farm animal practice .Blackwell scientific publications, Oxford, 1987, 12-42
    234. Saatkamp HW, Horst HS. Economic aspects of the control of classical swine fever. Vet Microbiol, 2000, 73(2-3) :221-238
    235. Sadhukhan R, Sen GC, Sen I. Synthesis and cleavage-secretion of enzymatically active
    
    rabbit angiotensin-converting enzyme in Pichia pastoris. J Biol Chem, 1996, 271:18310-18313
    236. Samaddar M, Catterall JF, Dighde RR. Expression of biologically active beta subunit of bovine follicle-stimulating hormone in the methylotrophic yeast Pichia pastoris. Protein ExprPurif, 1997,10:345-355
    237. Schirmbeck R, Bohmw, Andok. Nucleic acid vaccination primes hepatitisB Virus surfase antigen-specific cytotoxic T Lymphocytes in nonresponder mice. J Virol, 1995, 69:5925
    238. Schneider R, Unger G, Stark R et al. Identification of a structural glycoprotein of an RNA virus as a ribonuclease. Science, 1993, 261:1169-1171
    239. Scorer CA, Buckholz RG, Clare JJ et al. The intracellular production and secretion of HIV-1 envelope protein in the methylotrophic yeast Pichia pastoris. Gene, 1993, 136:111-119
    240. Scorer CA, Clare JJ, Mccombie WR et al. Rapid selection using G418 of high copy number tramsformants of pichia pastoris for high-level foreign gene expression. Bio/Technology, 1994, 12: 181-174
    241. Sharp PM, Tuohy TM, Mosurski KR. Codon usage in yeast: cluster analysis clearly differentiates highly and lowly expressed genes. Nucleic Acids Res. 1986, 14(13) :5125-43.
    242. Shiping Zh, Geoffrey Z and Emanuel G. Low usage codons in Escherichia coli,yeast, fruit fly and primates.l991,Gene,105:61-72
    243. Shiping ZH, Geoffrey Z, Emanuel G. Low-usage in Escherichia Coli,yeast,fruit fly and primanes. Gene, 1991, 105:61-72
    244. Siegei RS. Methylotroyphic yest Pichia pasteur produced in high-cell-density fementation with high cell yields as vehide for recombinant protein production. Biotechnology and Bioegineering, 1989, 34: 403-404
    245. Siegei RS, Buckholz RG, Thill GP et al. Production of epidermal growth factor in methylogrophic yeast cells. European Patent Application. 1990
    246. Sim BK, O'Reilly MS, Liang H et al. A recombinant human angiostatin protein inhibits experimental primary and metastic cancer. Cancer Res, 1997, 57:1329-1334
    247. Simon S, Massouli J. Cloning and expression of acetylcholinesterase from electrophorus. Splicing pattern of the 3'exons in vivo and in transfected mammalian cells. J Biol Chem, 1997, 272:33045-33055
    248. Sizova DV, Kolupueva VG, Peston TV et al. Specific interaction of eukaryotic translation initiation factor 3 with the 5 ' nontranslated regions of hepatitis C virus and classical swine fever virus. J Virol, 1998, 72(6) :4775-4782
    
    
    249. Skory CD, Freer SN, Bothast RT. Expression and secretion of the Candida wickerhamii extracellular β-glucosidase gene,bglB,in Saccharomyces cerevisiae. Curr Genet, 3996, 30:417-422
    250. Smith PM, Suphioglu C, Griffith IJ et al. Cloning and expression in yeast Pichia pastoris of a biologically active form of Cyn d l, the major allergen of Bermuda grass pollen. J.Allergy Clin Immunol, 1996, 98:331-343
    251. Sreekrishna K, Nelles L, Potenz R et al. High-level expression,purification,and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris. Biochemistry, 1989, 28:4117-4125
    252. Sreekrishna K, Tschopp J F, FucR M. Invertase gene (SUC2) of saccharomyces cere uisiae as a dominant marker for transformation of pichia pastoris. Gene, 1987, 59(1) : 115-125
    253. Stadejek T, Vilcek S, Lowings JP et al. Genetic heterogenety of classical swine fever virus in central Europe. Virus Res, 1997,52:195-204
    254. Stark R, Rumenapf G, Meyers et al. Geenomic localization of hog cholera virus glycoproteins. J Virology, 1990, 174: 286-289.
    255. Stark R. Processing of pestivirus polyprotein:cleavage site between autoprotease and nucleocapsid protein of classical swine fever virus. J Virol. 1993, 67:7088-7095
    256. Steffeus S, Thiel H-J, Behrens S-E et al. The RNA-dependent RNA polymerase of different members of the family flaviviridae exhibit similar properities in vitro. J Gen Virol, 1999, 80:2583-2590
    257. Stegeman A, Elbers A, De Smit H et al. The 1997-1998 epidemic of classical swine fever in the Netherlands. Vet Microbiol, 2000, 73:183-196
    258. Steidler L, Fiers W, Remaut E. Efficient specific release of Poriplasmic Proteins from Escherichia coli using temperature induction of cloned Kil gen of pMB9. Biotech Bioeng, 1994,44(9) : 1074-1082
    259. Steinlein LM, Graf TN, Ikeda RA. Production and purification of N-terminal half-transferrin in Pichia pastoris. Protein Expr Purif, 1995, 6:619-624
    260. Su W, Huber SC, Crawford NM. Identification in vitro of a post-translational regulatory site in the hinge 1 region of Arabidopsis nitrate reductase. Plant Cell, 1996, 8:519-527
    261. Sugrue RJ, Fu J, Howe J, Chan YC. Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles. J Gen Virol, 1997, 78:1861-1866
    262. Summerfield A, Hofmann MA, Mccullough KC. Low density blood granulocytic cells induced during classical swine fever are targets for virus infection. Vet Immunol
    
    Immunopathol, 1998, 63(3) :289-301
    263. Summerfield A, Kuotig SM, McCullough KC. Lymphocyte appoptosis during classical fever virus. Res Vet Sci, 1999, 67(1) :53-57
    264. Sun J, Bottomley S P, Kumar S et al. Recombinant caspase-3 expressed in Pichia pastoris is fully activated and kinetically indistinguishable from the native enzyme. Biochem. Biophys.Res Commun, 1997,238:920-924
    265. Sun J, Coughlin P, Salem HH et al. Production and characterization of recombinant human proteinase inhibitor 6 expressed in Pichia pastoris. Biochim Biophys Acta, 1995, 1252, 28-34
    266. Susa M, Konig M, Saalmuller A et al. Pathogenesis of classical swine fever: B-lymphocyte deficiency caused by hog cholera virus. J Virol, 1992, 66:1171-1175
    267. Talmont F, Sidobre S, Demange P et al. Expression and pharmacological characterization of the human μ-opioid reception in the methylotrophic yeast Pichia pastoris. FEBS Lett, 1996, 394:268-272
    268. Tanaka M, Suda T, Yatomi T et al. Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. J Immunol, 1997, 158:2303-2309
    269. Terpstra C, Wensvoort G. The protective value of vaccine induced neutralising antibody litres in swine fever. Vet Microbiol, 1998, 16:123-128
    270. Terpstra C, Bloemraad M, Gielkens AJL. The neutralising peroxidase-1 inked assay for detection of antibody against swine fever virus. Vet Microbiol, 1984, 9:113-120
    271. Thiel H-J, Stark R, Weiland E et al. Hog cholera virus:molecular composition of virions from a pestivirus. J Virol, 1991, 65:4705-4712
    272. Thiel HJ, Meyers G, Stark R et al. Molecular characterization of positive-strand RNA viruses: pestiviruses and the porcine reproductive and respiratory syndrome virus (PRRSV). Arch Virol Suppl. 1993, 7:41-52. Review.
    273. Thompsons, Clarke AR, Pow AM et al. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell, 1989, 56:313-321
    274. Trant JM. Functional expression of recombinant spiny dogfish shark(Squalus acanthias)cytochrome P450c17(17 a-hydroxylase/C 17,20-lyase) in yeast(Pichia pastoris). Arch Biochem Biophys, 1997, 326:8-14
    275. Tratschin JD, Moser C, Ruggli N et al. Classical swine fever virus leader proteinase Npro is not required for viral replication in cell culture. J Virol, 1998, 72(9) :7681-7684
    276. Trautwein G. Pathology and pathogenesis of the disease.Martins Nijhoff publishing,
    
    Boston, USA, 1988, 27-54
    277. Trawinski A, Trawinska J. Wplyw pH na wirulencje wirusu pomoru w miesie swinskim. Med Wet, 1949, 5:416-417
    278. Trujillo LE, Arrieta JG, Dafhnis F, Garcia J, Valdes J, Tambara Y, Perez M, Hernandez L.Fructo-oligosaccharides production by the Gluconacetobacter diazotrophicus levansucrase expressed in the methylotrophic yeast Pichia pastoris. Enzyme Microb Technol. 2001, 28(2-3) :139-144.
    279. Trimble RB, Atkinson PH, Tschopp JF et al. Structure of oligosaccharides on saccharomyces SUC2 invertase secreted by the methylotrophic yeast pichia pastoris. J Biol Chem, 1991, 266: 22807-22817
    280. Trucksis M, Conn TL, Fasano A et al. Production of Vibric cholerae accessory cholera enterotoxin(Ace) in the yeast Pichia Pastoris Infea. Immun, 1997, 665:4984-4988
    281. Tschopp JF, Cregg JM. Heterologous gene expression in methylotrophic yeast. Biotechnology. 1991, 18:305-22. Review.
    282. Tschopp JF, Brust PF, cregg JM et al. Expression of the lacZ gene from two methanol-regulated promoters in Pichia pastoris. Nucleic Acids Res, 1987, 15:3859-3876
    283. Tschopp J F, Sverlow G, Kosson R et al. High-level secretion of glycosylated invertase in the methylotrophic yeast,Pichia pastoris. Bio/Technology , 1987, 5:1305-1308
    284. Uchijima M, Yoshida A, Nagata T et al. Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class Ⅰ-restricted T cell responses against an intracellar.
    285. Van Gennip HGP, Van Rijn PA.Widjojoatmodjo MN et al. Chimeric classical swine fever viruses containing envelope protein Erns or E2 of bovine viral diarrrhoea virus protect pigs against challenge with CSFV and inducea distinguishable antibody. Vaccine, 2001, 19:447-459
    286. Van Heeke G, Ott TL, Strauss A et al. High yield expression and secretion of ovine pregnancy recognition hormone interferon-tau by Pichia pastoris. J Interferon Cytokine Res, 1996, 16:119-126
    287. Van Nostrand WE, Schmaier AM, Neiditch BR et al. Expression,purification,and characterization of the Kunitz-type proteinase inhibitor domain of the amyloid β-protein precursor-like protein-2. Biochim Biophys Acta, 1994,1209:165-170
    288. Van Oirschot JT, Gielken ALJ, Moorman RJM et al. The Marker Vaccines.Virus Protein-specific antibody assays and the control of Aujeszky's disease. Vet Microbiol, 1990,23:85-101
    
    
    289. van Oirschot JT, Terpstra CA. A congenital persistant swine fever infection.clinical and virological observations.Ⅱ.Immue response to swine fever virus and unrelated antigens. Vet Microbiol, 1977,2:121-142
    290. van Oirschot JT. Hog cholera.In:Shaw,BE et al. (Eds) Diseases of swine.9th Edition, Iowa state university press, Iowa, 159-172
    291. Van Riji PA, Van Gennip HGP, Demeijer EJ. Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia. J Gen Virology, 1993, 74: 2053-2060
    292. Van Rijin P A . Antigen structure of envelope glycoprotein El of hog cholera virus. J Journal of general virology, 1994, 68:3934-3942
    293. Van Rijin PA et al. A preliminary map of epitopes on envelope glycoprotein El of HCV strain Brescia. J Veterinary Microbiology, 1992, 33:212-230
    294. van Rijl M, Wensvoort G, Kluyver E et al. Live attenuated pseudorabies virus expressing envelope glycoprotein El of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol, 1991, 65,2761-2765
    295. Van Rijn PA, Van Gennip HGP, Demeijer EJ. Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia. J Gen Virology, 1993, 74: 2053-2060.
    296. van Rijn PA, Bossers A, Wensvoort G et al. Classical swine fever virus(CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J Gen Virol, 1996,77:2737-2745
    297. Van Rijn PA, Miedema GKW, Wensvoort G et al. Antigenic structure of envelope enveloprotein El of hog cholera virus. Journal of virology. 1994, 68(6) :3934-3942
    298. van Rijn PA, van Gennip HGP, de Meijer EJ et al. Epitope mapping of envelope glycoprotein El of hog cholera virus strain Brecia. J Gen Virol, 1993, 74:2053-2060
    299. VanZiJietal. J.Virol. 1991,65:1179-1182
    300. van Zijl M, Wensvoort, de Kluyver EP et al. Live attenuated pseudorabies virus expressing envelope glycoprotein El of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol. 1991, 65, 2761-2765
    301. Vedvick T, Buckholz RG, Engel M et al. High-level secretion of biologically active aprotinin from the yeast Pichia pastoris. J Ind Microbiol, 1991, 7:197-202
    302. Velander WH, Johnon JL, Page RL et al. High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human Protein C. Peoc Natl Acad Sci USA, 1992, 89:12003-12007
    303. Vilcek S, Paton DJ. Application of genetic methods to study the relationship between classical swine fever virus outbreaks. Res.Vet.Sci, 1998, 65:89-90
    
    
    304. Vileck S, Paton D, Lowings P et al. Genetic analysis of pestiviruses at the 3' end of the genome. Virus Genes, 1999, 18:107-114
    305. Vileck S, Stadejek T, Ballagi-Pordany A et al. Genetic variability of classical swine fever virus. Virus Res, 1996, 43:137-147
    306. Vollmer P, PetersM, Ehlers M et al. Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor. J Immunol Methods, 1996,199:47-54
    307. Vozza LA, Wittwer L, Higgins DR et al. Production of a recombinant bovine enteokinase catalytic subunit in the methylotrophic yeast Pichia pastoris. Bio/Technology, 1996, 14:77-81
    308. Vuorela A, Myllyharju J, Nissi R et al. Assembly of human prolyl 4-hydroxylase and type Ⅲ collagen in the yeast Pichia pastoris:formation of a stable enzyme tetramer requires coexpression with collagen and assembly of a stable collagen requires coexpression with prolyl 4-hydroxylase. EMBO J, 1997, 16:6702-6712
    309. Warrener P, Collectt MS. Pestivirus NS3(P80) protein possesses RNA helicase activity. J Virol, 1995, 69(3) : 1720-1726
    310. Waterham HR, Digan ME, Koutz PJ et al. Isolation of the Pichia pastoris glyceraldehyde-3-phosphate deydyogenase gene and regulation and use of its promoter. Gene, 1997, 186:37-44
    311. Webb NR, Summers MD. Expression of proteins using recombinant baculoviruses. Technique, 2:173-188
    312. Wegner G. Emerging applications of methytrophic yeasts FEMS Microbiol Rev, 1990, 87:279-284
    313. Weiss HM, Haase W, Michel H et al. Expression of functional mouse 5-HT5A serotonin receptor in the methylotrophic yeast Pichia pastoris:pharmacological characterization and localization.FEBS Lett, 1995, 377:451-456
    314. Welland E, Stark R, Haas B et al. Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer. J Virol, 1990, 64:3563-3569
    315. Wenhui W, Mark AB, Bradley AP et al. Modeling pichia pastoris growth on methanol and optimizing the production of a recombinant protein.the Heavy-chain fragment C of Botulinum neurotoxin、serotypeA. Biothchnology and Biengineering, 2000, 20(1) :1-8
    316. Wensvoort G, Bloemraad M, Terpstra C. An enzyme immunoassay employing monoclonal antibodies and detecting specifically antibodies to classical swine fevervirus. Vet Microbiol, 1988, 17:129-140
    317. Wensvoort G, Terpstra C, Boonstra J et al. Production of monoclonal antibodies against
    
    swine fever virus and their use in laboratory diagnosis. Vet Microbiol, 1986, 12: 101-108
    318. Wensvoort G, Terpstra C, de Kluyver EP et al. Antigenic differentiate of pestivirus strains with monoclonal antibodies against hog cholera virus. Vet Microbiol, 1989, 21:9-20
    319. Wensvoort G. Topographical and functional mapping of epitopes on hog cholera virus with monoclonal antibodies. J Gen Virol, 1989, 70:2865-2876
    320. White CE, Hunter MJ, Meininger DP et al. Large-scale expression.purification and charaterization of small fragments of thrombomodulin:the roles of the sixth domain and of methionine 388. proteinEng, 1995,8:1177-1187
    321. WHO. WHO guidelines for assuring the quality of DNA Vaccines. J Biologicals, 1998, 26:205-212
    322. Wickham TJ, Davis T, Granados RR et al. Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system. Biotechnol. Prog, 1992, 8:391-396
    323. Widjojoamodjo MN, van Gennip HGP, de Smit AJ et al. Comparative sequence analysis of classical swine fever virus isolates from the epizootic in the Netherlands in 1997-1998. Vet Microbiol, 1999,66:291-299
    324. Widjojoat moajo MN, Van Gennip HGP, Bouma A. Classical swine fever virus Erns deletion mutants:trans-complementation and potential use as nontransmissible, modified, Live-attenuated marker vaccines. J virology, 2000,74(7) : 2973-2980
    325. Wiles AP, Shaw G, Bright J et al. NMR studies of a viral protein that mimics the regulators of complement activation. J M Biol, 1997,272:253-265
    326. Williams TA, Michaud A, Houard X et al. Drospholia melanogaster angiotensin I-converting enzyme expressed in Pichia pastoris resembles the C domain of the mammalian homologue and does not require glycosylation for secretion and enzymic activity. Biochem J, 1996,318:125-131
    327. Wirz B, Tratschin JD, Mueller HK et al. Detection of hog cholera virus and differentiation from other pestivirus by polymerase chain reaction. J Clin Microbiol, 1993, 31:1148-1154
    328. Wise GH. Eradication of hog cholera from the united states.In:woods,G T.(Eds),practices in veterinary public health and preventive medicine in the united stares. Iowa state university press, 1986, 199-223
    329 Wiskerchen M, Belzer SK, Collett MS. Pestivirus gene expression: the first protein product of the bovine viral diarrhea virus large open reading frame, p20, possesses proteolytic activity. J Virol. 1991,65(8) :4508-4514.
    330. Wright G, Carrer A, Cottom D et al. High level expression of active human alpha-l-antitrypsin in the milk of transgenic sheep. Biotechnology(N Y), 1991, 9(9) :
    
    830-834
    331. Wuebbens MW, Roush ED, Decastro CM et al. Cloning ,sequencing,and recombinant expression of the porcine inhibitor of carbonic anhydrase: a novel member of the transferrin family. Biochemistry, 1997, 36:4327-4336
    332. Wulfing C, Pluckthun A. Protein folding in the periplasm of Escherichia coli. Mol Microbiol, 1994, 12(5) :685-692
    333. Wulfing C, PlucKthun A. Correctly folded T-cell receptor fragment in the periplasm of Escherichia Coli. J MolBiol, 1994, 243(3) :655-669
    334. Wunderlich M, GlockshuberR. In uitro control of fedox potentiol during protein folding cutalyzed by bacterial protein disulfide-isomerase(DsbA). J.Biol chem, 1993, 268(33) : 24547-24550
    335. Xinglong Y, Changchun T, Hongwei L. DNA-mediated protection against classical swine fever virus. Vaccine, 2001, 19:1520-1525
    336. Yamada M, Azuma T, Mastsuba T et al. Secretion of human intracellular aspartic proteinase cathepsin E expressed in the methylotrophic yeast,Pichia pastoris and characterization of produced recombinant cathepsin E. Biochim.Biophys.Acta, 1994, 1206:279-285
    337. Yang YS, Yang MC, Tucker PW et al. Nonoenchances the association of many DNA-binding proteins to their targets. Nucleic Acids Res, 1997, 25:2284-2292.
    338. Young RS, Seeyoung CH, Jong-Seok L et al. Immunogenincity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses. Vaccine, 2001, 19: 2955-2964
    339. Yu M, Wang LF, Shiell BJ et al. Fine mapping of a C-terminal linear epitope highly conserved among the major envelope glycoptrotein E2(gp51 to gp54) of different pestivirus
    340. Zhang JG, Owczarek CM, Ward LD et al. Evidence for the formation of a heterotrimeric complex of leukaemia inhibitory factor with its receptor subunits in solution. Biochem J, 1997,325:693-700
    341. Zhu A, Monohan C, Wang ZK et al. Expression, purification and characterization of recombinant a-N-acetylgalactosaminidase produced in the yeast Pichia pastoris. Protein Expr Purif, 1997, 8:456-462
    342. Zhu A, Monohan C, Zhang Z et al. High-level expression and purification of coffee bean α-galactosidase produced in the yeast Pichia pastoris. Arch Biochem Biophys, 1995, 324:65-70
    343. Zhu H, Shi J, Cregg JM et al. Reconstitution of highly expressed human heart muscle carnitine palmitoyltransferase Ⅰ. Biochem.Biophys.Res Commun, 1997, 239:498-502
    344. Zhu X, Wu S, Letchworth GJ Ш. Yeast-secreted bovine herpesvirus type 1 glycoprotein D
    
    
    345.奥斯泊F,布伦特R,金斯顿RE等.精编分子生物学实验指南.北京:科学出版社,1999
    346.蔡志强,徐步进.转基因植物作为生物反应器生产口蹄疫疫苗的研究进展.生物工程进展,2001,21 (4):8~10.
    347.陈丹,杨丰,王玮等.鲈鱼生长激素甲醇酵母中的胞内表达.生物化学与生物物理进展 1998,25 (2):140~143
    348.陈红星,杨晓,黄培堂.乳腺生物反应器制备中表达载体的发展.生物工程学报,2002,18 (2):136~139
    349.陈新华,杨林,陈曲侯.人白介素-12(P40)亚基在巴斯德毕赤酵母中的表达.中华医学遗传学杂志,2001,18 (2):132~134
    350.陈哲宇,黄爱军,何成等.人GDNF在甲醇酵母及家蚕幼虫中的表达.生物工程学报,2000,16 (5):561~565
    351.程颖,高卜渝,宋大新等.转甲状腺素蛋白基因在酵母中的表达.生物工程学报 1999,15 (4):428~433
    352.崔蕴霞,明文玉,银巍等.人重组白蛋白基因在巴斯德毕赤酵母中的高效表达.微生物学报,2001,41 (2):244~246
    353.崔治中.动物基因工程疫苗安全性及免疫效力的评估.中国兽医杂志,1997,31 (1):53~57
    354.丁秀云,李春海,朱运峰等.基质金属蛋白酶-2在酵母系统中表达的初步研究.生物化学与生物物理进展,1999,26 (3)291~293
    355.杜念兴.猪瘟的感染和免疫.畜牧学兽医,1991,23 (2):85~87
    356.范乔,刘宏迪.甲醇营养型酵母表达外源蛋白的特点及策略.微生物学通报,1999,26 (4):304~306
    357.范书才.兽用基因工程生物制品的安全问题.中国兽药杂志,2000,34 (6):39~42
    358.苟克勉,安晓荣,田见晖等.动物乳腺生物反应器的现状和趋势.生物工程学,2002,18 (2):144~148
    359.郭美锦,吴康华,储炬等.毕赤氏酵母工程菌高密度发酵表达恶性疟原虫融合抗原的研究,生物工程学报,2001,17 (4):456~459
    360.郭美锦,庄英萍,储炬等.重组巴氏毕赤酵母高密度发酵表达rHSA.微生物学报,2002,42(1):62~68
    361.韩雪清,李红卫,刘湘涛等.中国猪瘟兔化弱毒(C-株)兔脾组织毒部分基因的序列分析—gp55、P54、P80等基因测序方法的研究和P54基因的序列分析.中国兽医科技,1998,28 (6):13~17
    362.韩雪清,李红卫,刘湘涛等.中国猪瘟兔化弱毒株(C-株)兔脾组织毒主要保护性抗原E2(gp55)基因序列分析.畜牧兽医学报,2001,32 (1):52~57
    
    
    363.韩雪清,刘湘涛,张涌等.猪瘟病毒E2基因在p.pastoris中的表达及其免疫活性的初步研究.生物工程学报,2002,2 (18):208~211
    364.韩雪清,刘湘涛,赵启祖等.猪瘟病毒遗传发生关系分析.中国兽医科技,1999,29 (6):3~7
    365.何宇佳,聂东宋,徐辉明等.虎纹镇痛活性肽在毕赤酵母中的分泌表达.生物化学与生物物理进展,2001,28 (6):853~857
    366.黄岩山,董勇,李辉等.毕赤酵母表达重组人白细胞介素11的纯化鉴定.生物工程学报,2001,17 (3):230~250
    367.蒋太交,吉鑫松,章如安等.甲醇酵母pichia pastoris高水平表达有活性的辣根过氧化物酶.生物化学与生物物理进展,1999,26 (6):584~587
    368.瞿礼嘉 等著.现代生物技术导论(第一版).高等教育出版社,北京,1998.
    369.李成等.应用电镜技术对猪瘟病毒的研究.中国兽医科技.1989,7:24~25
    370.李红卫,涂长春,金扩世等.猪瘟病毒石门株与兔化弱毒株主要保护性抗原E2基因的序列测定.见谢庆阁,翟中和主编.畜禽重大疫病免疫防制研究.北京:中国农业科技出版社,1997,22~26
    371.李红卫,涂长春,吕宗吉等.两个猪瘟病毒野毒株gp55基因抗原编码区序列的分析及比较.中国病毒学,1997,12 (4):354~357
    372.李红卫.猪瘟病毒保护性抗原E2基因的克隆、序列分析及在大肠杆菌中的表达[D].博士论文,1997
    373.李晶,赵晓祥,沙长青等.甲醇酵母表达系统的研究进展.生物工程进展,1999,19 (2):17~20
    374.李满.大肠杆菌中重组蛋白包含体的形成机制及其影响因素.生物工程进展,1992,12 (1):34~37
    375.李振刚主编,分子遗传学.北京,科学出版社,2000
    376.刘建忠.转基因小鼠乳腺表达人瘦蛋白的研究.博士论文,1999,43
    377.刘森,梁国栋.利用动物乳腺生物反应器生产药用蛋白.生物工程学报,2000,16 (4):421~424
    378.刘湘涛,韩雪清,刘伯华等,猪瘟流行毒Erns基因的序列分析.中国农业科学,2000,33 (4):75-81
    379.刘湘涛,赵启祖,李忠润等.猪瘟病毒(HCV)的研究进展和存在的问题.兰州大学学报(自然科学版.遗传学专辑),1995,31:157~161
    380.刘湘涛,赵启祖,李忠润等.猪瘟病毒和猪瘟防制见:谢庆阁,翟中和主编.畜禽重大疫病防制研究进展.北京:中国农业科技出版社,1996
    
    
    381.刘一平,杨晓,徐晓玲.SMAD4在嗜甲醇酵母中的表达及鉴定.生物化学与生物物理学报,2000,32 (3):239~242
    382.卢圣栋主编.现代分子生物学实验技术.北京,中国协和医科大学出版社,1999
    383.陆军,严维耀,郑兆鑫.基因疫苗—防法疫病的新武器.生命的化学,2000,20 (1):17~19
    384.马文军,于康震.禽流感疫苗.中国预防兽医学报,1999,21 (5):380~400
    385.聂东宋,李敏,徐辉明等.重组虎纹捕鸟蛛毒素-1在巴氏毕赤酵母中的表达及纯化,生物工程学报,2002,18 (2):172~177
    386.裴建武,郭玉璞,周顺伍.传染性法氏囊炎基因工程疫苗研究进展.中国兽药杂志,1997,31 (3):52~53
    387.彭毅,步威,康良仪.甲醇酵母表达系统.生物技术通报,2000,(1):38~41
    388.彭毅,杨希才,康良仪,影响甲醇酵母中外源蛋白表达的因素.生物技术通报,2000,(4):33~36
    389.邱惠深,郎洪武,王在时.猪瘟野毒的分离鉴定及猪瘟弱毒疫苗与猪瘟野毒株免疫相关性研究.见:谢庆阁,翟中和主编.畜禽重大疫病免疫防制研究.北京,中国农业科技出版社,1997,101~104
    390.邱惠深,王在时,廖国安.猪瘟单抗诊断试剂的研究.中国畜禽传染病,1991,(6):20~26
    391.邱荣德,朱建蓓,王垒,人P53蛋白在巴斯德毕赤酵母中的表达.生物工程学报.
    392.萨姆布鲁克等著,金冬雁译.分子克隆试验指南(第2版).科学出版社,北京,1992
    393.沈俊卿,屈贤铭.抗菌肽ABP3基因的克隆及其在pichia pastoris中的表达.生物工程学报,1999,15 (4):489~493
    394.史国瑞 译,陈文樾 校.瘟病毒分类.国外兽医学-畜禽传染病,1993,13 (1):1~2
    395.宋钢,官孝群,莫炜等.人微小纤溶酶原活性中心丝氨酸突变体基因在毕赤酵母中的表达.基因,2002,(2)
    396.宋伦,任蕴芳,王建安等,人tpoN端结构在毕赤酵母中的分泌表达及产物鉴定.中华微生物学和免疫学杂志,2002,(1)
    397.苏慧慈,刘彦仿著.原位PCR.北京,科学出版社,1997
    398.童光志.生物技术在预防兽医学领域的应用及发展趋势.生物技术通报,1997,(6):1~4
    399.王敏华,江金益,范必勤等.猪瘟病毒石门株基因组cDNA片断的扩增与克隆测序.畜牧兽医学报,1996,27 (5):436~442
    400.王在时.猪瘟防制研究的回顾和展望.见:谢庆阁,翟中和主编.畜禽重大疫病免疫防制研究进展.中国农业科学技术出版,1996,64~71
    401.王镇,闵光伟,李明义等.猪瘟病毒的形态结构与形态发生.微生物学报,2000,40 (3):237~242
    
    
    402.王卓华,叶凯,徐洪等.庚型肝炎病毒E2区cDNA在毕赤酵母中的表达及抗原性鉴定.生物工程学报,2002,18 (2):187~190
    403.魏滨,谷淑燕,李燕等.戊型肝炎病毒结构区orr2蛋白在巴氏毕赤酵母中的胞内表达与纯化的初步研究.病毒学报,2001,17 (1)
    404.吴乃虎主编.基因工程原理(第2版,上册).北京,科学出版社,2001
    405.吴石金,任军.畜禽基因工程疫苗研究现状及其应用前景,畜禽业,1999,(9):13~14
    406.吴艳涛,刘秀梵.新城疫基因工程疫苗研究,中国兽药杂志,2001,35 (4):56~59
    407.辛利,张励,徐韧等,人血管抑素在毕氏酵母中的表达及其活性测定.生物化学与生物物理学报,2001,33 (3):237~343
    408.阎锡蕴,汤健,黄宇鸿.人血管内皮细胞生长因子在毕赤酵母中的高效表达.生物工程学报,2000,16 (4):531~533
    409.姚斌,张春义等.高效表达具有生物学活性的植酸酶的毕赤酵母.中国科学(C辑),1998,28 (3):237~243
    410.殷震,刘景华主编.动物病毒学(第2版).北京,科学出版社,1997
    411.余兴龙,涂长春,李红卫等.猪瘟病毒E2基因真核表达质粒的构建及基因疫苗的研究.中国病毒学,2000,15 (3):264~
    412.张克忠,卢大儒,邱信芳.人凝血1x因子乳腺组织特异性表达载体的构建及其在奶山羊乳腺中的分泌性表达.生物工程学报,1997,13 (4):419~422
    413.赵启祖,谢庆阁.抗猪瘟基因工程研究[J].兰州大学学报(自然科学版),1994,30(增刊),169~170.
    414.赵翔,霍克克,李育阳.毕赤酵母的密码子用法分析.生物工程学报,2000,16 (3):308~311
    415.周鹏程,陆宇,陈建国.猪瘟病毒E2(gp55)基因的克隆表达及其DNA疫苗的初步研究.微生物学报,2000,40 (3):223~251
    416.周则迅,袁汉英,何炜.乙肝病毒表面抗原SA-28融合基因在酵母中的组成型表达.复旦学报(自然科学版),2000,39 (3):264~268